The Future of Healthcare M&A: Regulatory Challenges, Private Equity, and Physician Transactions
Release Date: 02/20/2025
Structuring Smarter Healthcare Transactions for Sustainable Growth
Transaction Healthcare
Dean Gould is a Member of Dykema Gossett PLLC, a national full-service law firm. In his role, he advises healthcare industry clients and dental service organizations (DSOs) on strategic transactions, including acquisitions, mergers, recapitalizations, and divestitures. Dean also assists clients in forming regulatory-compliant practice management structures and equity incentive arrangements for key employees. In this episode… The healthcare transaction landscape is becoming increasingly complex as providers, investors, and advisors navigate evolving regulations and market pressures. With new...
info_outline
Top Lessons From Healthcare M&A Leaders: A Compilation
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
Transforming Patient Navigation Through Tech and Tenacity
Transaction Healthcare
Rani Khetarpal is the Co-founder and CEO of NavPoint Health, a company dedicated to advancing patient navigation and care coordination through innovative technology solutions. With over 25 years of experience across pharmaceuticals, digital health, and value-based care, she brings a strategic and mission-driven approach to transforming healthcare. Previously, she held leadership roles at companies including GSK, Teva, and CVS, and founded and exited Global Transitional Care, the first Medicare-recognized transitional medicine provider. Rani is also the President of the Academy of Oncology...
info_outline
How AI and Spatial Biology Are Transforming Cancer Treatment and Clinical Trials
Transaction Healthcare
Dusty Majumdar is the CEO of PredxBio, a precision pathology company leveraging AI and spatial biology to transform cancer diagnostics and therapeutics. With over two decades of leadership experience in precision healthcare, he has held senior roles at the American Society of Clinical Oncology, IBM, Exact Sciences, and GE Healthcare. Dusty has spoken at numerous forums, including The Economist War on Cancer and a MIT plenary lecture on AI in healthcare. In this episode… Despite recent advances in cancer research, early detection and effective treatment remain major challenges. Traditional...
info_outline
How Health Law and Policy Shape the Future of Healthcare Transactions
Transaction Healthcare
Christopher (Chris) Raphaely is the Co-chair of the Health Care & Life Sciences Practice Group at Cozen O’Connor, a full-service law firm with practices in litigation, business, and government relations. In his role, he provides transactional and regulatory counsel to various healthcare providers and investors. With nearly three decades of experience in the healthcare industry, Chris specializes in mergers and acquisitions, payer negotiations, HIPAA compliance, and value-based payment arrangements. Before joining Cozen O’Connor, he served as Deputy General Counsel at Jefferson...
info_outline
2025 Healthcare M&A Outlook: Physician Practice Growth, Consolidation, and Equity Insights
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
Creating Patient-Driven Value in a Changing Healthcare Economy
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
The Future of Physician Practices: AI, Consolidation, and Private Equity Insights
Transaction Healthcare
Zak Eisenberg is the Vice President of Merritt Healthcare Advisors, which provides investment banking services to healthcare services organizations. In his role, he manages the strategic development and execution of ASC, surgical hospital, and physician practice transactions. Zak specializes in sourcing and analyzing transactions and capital and negotiating and structuring investments. Previously, he was a Biofund Venture Analyst at New Orleans Bioinnovation Center, a biotech and life science-focused venture capital firm, and led the analysis team at a renewable energy-focused private equity...
info_outline
The Evolving Landscape of Healthcare M&A
Transaction Healthcare
Bart Walker is a Partner at McGuireWoods, an international law firm, and a co-leader of the firm’s healthcare and life sciences industry team. In his role, he focuses on healthcare mergers and acquisitions, strategic joint ventures, and regulatory compliance, advising healthcare providers, private equity sponsors, and lenders. Bart’s clients include hospitals, ambulatory surgery centers, dental service organizations, urgent care providers, and large physician group practices. He has been recognized as an emerging leader in mergers and acquisitions by The M&A Advisor. In this episode…...
info_outline
The Future of Private Practice: Innovation, AI, and Patient Care
Transaction Healthcare
Dr. Michelle Nguyen, MD, is a Gastroenterology Specialist at Unio Specialty Care, a multi-specialty physician practice. As a board-certified gastroenterologist, she has over 15 years of experience specializing in esophageal diseases and quality metrics in colonoscopy. Dr. Nguyen has held leadership positions, including Chief of Gastroenterology in Santa Cruz and an Infusion Site Lead at the Palo Alto Medical Foundation. In this episode… Healthcare professionals often face a difficult choice: stay within large, structured health systems with financial stability or take the leap into...
info_outlineGary Herschman is a Member of Epstein Becker & Green, P.C., a firm specializing in healthcare and life sciences, where Gary co-chairs the healthcare transactions and M&A group. With over 30 years of experience in healthcare M&A, he represents hospitals, ASCs, physician groups, and home healthcare companies in consolidations, affiliations, joint ventures, physician alignments, and more. Among his many accolades, Gary has been listed in The Best Lawyers in America for Health Care Law from 2010 to 2025 and was named a 2024 Leader in Law by NJBIZ.
In this episode…
Navigating healthcare transactions is more complex than ever, with shifting regulations, increased scrutiny, and growing consolidation across the industry. Private equity firms and health systems are rapidly acquiring physician practices, leaving many providers uncertain about their future. Simultaneously, evolving federal and state laws add compliance challenges that can delay or even derail deals. How can healthcare transaction advisors and legal experts help navigate these evolving challenges to ensure successful transactions?
Healthcare M&A attorney Gary Herschman explains that proactive planning is crucial to overcoming regulatory hurdles and structuring tax-efficient deals. He emphasizes the importance of early consensus among physician groups and understanding state-specific approval requirements that can impact transaction timelines. Additionally, private equity investors recognize consolidation opportunities in fragmented outpatient markets like cardiology and orthopedics. Gary advises physicians in these sectors transitioning from hospital employment to private practice to leverage private equity partnerships for growth and value creation.
In this episode of Transaction Healthcare, Zak Eisenberg interviews Gary Herschman, a Member of Epstein Becker & Green, P.C., about navigating healthcare transactions in a shifting regulatory environment. Together, they explore strategies for addressing compliance pitfalls, structuring physician practice acquisitions, and managing antitrust concerns in M&A deals.